
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Explores the problem of high drug prices by taking a close look at the science of drug development, how the drug industry operates, how new drugs are discovered, and how the government affects and controls these processes. By examining recent changes in the pharmaceutical industry in more depth, the authors explain how more radical changes can both reduce prices and improve the flow of new drugs.
This book investigates the complex issue of high prescription drug prices and proposes solutions for both cost reduction and innovation improvement. The authors, drawing on their expertise in economics and the pharmaceutical industry, examine the scientific underpinnings of drug development, the operational structures of pharmaceutical companies, and the governmental influences on these processes. By dissecting recent shifts within the industry, they argue for the feasibility of significant reforms that can simultaneously lower prices and enhance the pipeline of new medications.
The Authority Perspective: This work is recognized for its in-depth analysis of the pharmaceutical industry and its contribution to the discourse on drug pricing and innovation. It offers a structured examination of the factors contributing to high costs and presents a framework for potential systemic improvements. The book is likely to appeal to policymakers, industry professionals, and informed consumers seeking a comprehensive understanding of these critical issues.
Page Count:
208
Publication Date:
2008-01-01
ISBN-10:
0132344491
ISBN-13:
9780132344494
No comments yet. Be the first to share your thoughts!